VDB
I agree with your monetary assessments, but want to clarify something. CVSI WILL SUCCEED with phase 1. I've been around pharma, so what we're waiting for is for them to file their IND. Last year they had a meeting with FDA and learned some valuable things. So they are now doing the analytical work and animal work and making sure they can reliably manufacture different doses of this to go with the nicotine gum. No small feat. When they get that done and file the IND, they will also include a protocol for the phase 1 study. Normally, Phase 1 is with healthy volunteers (i.e., non chewers), but in the best of all worlds, they would have access to chewers. They'll look at at least 2 doses of the drug/gum combination vs placebo (no CBD). They make sure they can measure blood levels and urine levels in a reliable fashion. At the end of that, they'll have valuable information about picking a dose (or two) for the Phase II study, in which they will definitely go into tobacco chewers. In this phase, they'll get a good idea about how well it works (efficacy) and the safety profile. My guess is after a successful phase 1 trial, someone will try to acquire them. And how bloody smart is CVSI that it can fund predominantly on the consumer sales. So people should chill for a year. They're killing it in sales and will continue to go up. The drug development program is continuing. Hang in there and don't sweat day to day variations. I look at SP multiple times a day, but that doesn't change my resolve. Confident that this is the stock of my lifetime. Have a great WE all.
MT
AI
Market Data 
Markets 
